Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses

Journal Article · · Viruses
DOI:https://doi.org/10.3390/v16030428· OSTI ID:2469892
Single-dose, immunogenic DNA (iDNA) vaccines coding for whole live-attenuated viruses are reviewed. This platform, sometimes called immunization DNA, has been used for vaccine development for flavi- and alphaviruses. An iDNA vaccine uses plasmid DNA to launch live-attenuated virus vaccines in vitro or in vivo. When iDNA is injected into mammalian cells in vitro or in vivo, the RNA genome of an attenuated virus is transcribed, which starts replication of a defined, live-attenuated vaccine virus in cell culture or the cells of a vaccine recipient. In the latter case, an immune response to the live virus vaccine is elicited, which protects against the pathogenic virus. Unlike other nucleic acid vaccines, such as mRNA and standard DNA vaccines, iDNA vaccines elicit protection with a single dose, thus providing major improvement to epidemic preparedness. Still, iDNA vaccines retain the advantages of other nucleic acid vaccines. In summary, the iDNA platform combines the advantages of reverse genetics and DNA immunization with the high immunogenicity of live-attenuated vaccines, resulting in enhanced safety and immunogenicity. This vaccine platform has expanded the field of genetic DNA and RNA vaccines with a novel type of immunogenic DNA vaccines that encode entire live-attenuated viruses.
Research Organization:
Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
NA0003525
OSTI ID:
2469892
Journal Information:
Viruses, Journal Name: Viruses Journal Issue: 3 Vol. 16; ISSN 1999-4915
Publisher:
MDPICopyright Statement
Country of Publication:
United States
Language:
English

References (133)

West Nile Virus: Review of the Literature journal July 2013
Recognition of cytosolic DNA by cGAS and other STING-dependent sensors: HIGHLIGHTS journal January 2014
Diversity within Natural Populations of Eastern Equine Encephalomyelitis Virus journal August 1993
Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin Vivo journal December 1997
A New Strategy in Design of (+)RNA Virus Infectious Clones Enabling Their Stable Propagation in E. coli journal March 2001
Electroporation for therapeutic DNA vaccination in patients journal December 2014
Climate change and threat of vector-borne diseases in India: are we prepared? journal February 2010
Development of an attenuated strain of chikungunya virus for use in vaccine production journal September 1986
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine journal March 1996
Chikungunya in Europe journal March 2008
Chikungunya: a re-emerging virus journal February 2012
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial journal June 2023
The prime-boost strategy: exciting prospects for improved vaccination journal April 2000
A ‘minimal’ approach in design of flavivirus infectious DNA journal December 2001
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus journal August 2000
TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus journal February 1999
Clinical burden of chikungunya virus infection journal January 2008
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial journal April 2024
Present and future arboviral threats journal February 2010
Yellow Fever: A Perennial Threat journal November 2022
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives journal December 2023
Intracellular sensing of viral DNA by the innate immune system journal December 2014
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention journal August 2013
An imported case of Chikungunya fever from Madagascar: Use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries journal January 2009
Chikungunya Virus: Possible Impact on Transfusion Medicine journal January 2010
Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases journal October 2007
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates journal September 2008
Development pathway for biodefense vaccines journal November 2009
Vaccines for Venezuelan equine encephalitis journal November 2009
Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates journal October 2010
Stability of RNA virus attenuation approaches journal March 2011
US Military contributions to the global response to pandemic chikungunya journal October 2012
Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine journal February 2013
Vaccination of healthcare personnel: Spotlight on groups with underlying conditions journal July 2014
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014 journal April 2015
Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus journal September 2015
Molecular characterization of the 17D-204 yellow fever vaccine journal October 2015
Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer journal October 2015
Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome journal May 2019
Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge journal April 2020
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice journal November 2014
Live attenuated vaccines: Historical successes and current challenges journal May 2015
Development of a human live attenuated West Nile infectious DNA vaccine journal October 2015
Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein journal January 2016
Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design journal January 2016
Next generation sequencing of DNA-launched Chikungunya vaccine virus journal March 2016
Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice journal December 2017
Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model journal December 2003
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection journal January 2010
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates journal August 2011
Vaccines: past, present and future journal April 2005
DNA vaccines: ready for prime time? journal October 2008
The regulation and functions of the nuclear RNA exosome complex journal January 2016
Transmission cycles, host range, evolution and emergence of arboviral disease journal October 2004
The arrival, establishment and spread of exotic diseases: patterns and predictions journal April 2010
Biology and pathogenesis of chikungunya virus journal July 2010
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines journal July 2023
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine journal November 2022
Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine — Preliminary Report journal October 2017
Venezuelan equine encephalitis emergence: Enhanced vector infection from a single amino acid substitution in the envelope glycoprotein journal July 2004
Arbovirus high fidelity variant loses fitness in mosquitoes and mice journal September 2011
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus journal August 2003
DNA-launched live-attenuated vaccines for biodefense applications journal April 2016
The use of electroporation to deliver DNA-based vaccines journal December 2023
Chikungunya vaccines in development journal November 2015
Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine journal June 2020
Prophylaxis and Therapy for Chikungunya Virus Infection journal August 2009
Clinical Applications of DNA Vaccines: Current Progress journal July 2011
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects journal June 2006
Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study journal June 2023
DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice journal February 2014
Raising Expectations For Subunit Vaccine journal November 2014
Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone journal April 2015
Genetic divergence of Chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic journal July 2007
DNA vaccines: an historical perspective and view to the future: The past and future of DNA vaccines journal December 2010
The landscape of transcription errors in eukaryotic cells journal October 2017
ENTOMOLOGY: A Mosquito Goes Global journal May 2008
Unfilled Vials journal January 2016
A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates journal March 2011
Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines journal July 2015
Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine journal November 2010
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine journal October 2007
Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice journal March 2014
Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein journal June 2012
Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine journal August 2001
Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses journal December 2001
An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector journal October 2003
Attenuation of Bunyavirus Replication by Rearrangement of Viral Coding and Noncoding Sequences journal June 2005
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. journal January 1993
A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development journal August 2016
The alphaviruses: gene expression, replication, and evolution journal September 1994
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study journal December 2015
V ENEZUELAN E QUINE E NCEPHALITIS journal January 2004
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures journal January 2013
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss journal December 2014
Vaccination in children with allergy to non active vaccine components journal February 2015
Chikungunya: A Potentially Emerging Epidemic? journal April 2010
A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates journal January 2011
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses journal April 2015
Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate journal September 2015
The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines journal January 2022
Epidemiology of yellow fever virus in humans, arthropods, and non-human primates in sub-Saharan Africa: A systematic review and meta-analysis journal July 2022
Clinical potential of electroporation for gene therapy and DNA vaccine delivery journal December 2015
Clinical vaccine development for H5N1 influenza journal July 2013
Production and purification of plasmid DNA vaccines: is there scope for further innovation? journal October 2014
Electroporation-enhanced delivery of nucleic acid vaccines journal December 2014
DNA vaccines for biodefense journal December 2009
New Japanese encephalitis vaccines: alternatives to production in mouse brain journal March 2011
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors journal August 2011
Chikungunya virus and prospects for a vaccine journal September 2012
Synthetic DNA vaccine strategies against persistent viral infections journal May 2013
Improving DNA Vaccine Performance Through Vector Design journal August 2014
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus journal May 2002
Characterization of Virulent West Nile Virus Kunjin Strain, Australia, 2011 journal May 2012
The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus journal November 2023
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines journal November 2023
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits journal March 2022
Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview journal October 2023
The Present and Future of Yellow Fever Vaccines journal September 2021
Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development journal February 2019
Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources journal July 2021
Ecology of West Nile Virus in North America journal September 2013
Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes journal March 2020
Development of Pandemic Vaccines: ERVEBO Case Study journal February 2021
DNA vaccines: A simple DNA sensing matter? journal October 2013
Mesenteronal Infection Threshold of an Epizootic Strain of Venezuelan Encephalitis Virus in Culex (Melanoconion) Taeniopus Mosquitoes and Its Implication to the Apparent Disappearance of This Virus Strain from an Enzootic Habitat in Guatemala journal September 1982
Vector Competence of Culex (Melanoconion) Taeniopus for Allopatric and Epizootic Venezuelan Equine Encephalomyelitis Viruses journal January 1987
Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks. journal March 1999
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. journal June 2000
Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. journal January 2001
Vector Competence of Culex (Melanoconion) taeniopus for Equine-Virulent Subtype IE Strains of Venezuelan Equine Encephalitis Virus journal June 2010
History of U.S. Military Contributions to the Study of Viral Encephalitis journal April 2005
Serologic Evidence of Venezuelan Equine Encephalitis in some wild and Domestic Populations of Southern Texas journal April 1975